EVE Health Group Limited (ASX:EVE)
Australia
· Delayed Price · Currency is AUD 0.0210
+0.0010 (5.00%)
Mar 10, 2026, 1:59 PM AEST
EVE Health Group Income Statement
Financials in millions AUD. Fiscal year is July - June.
Millions AUD. Fiscal year is Jul - Jun.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | 2020 - 2016 |
|---|---|---|---|---|---|---|---|
Period Ending | Dec '25 Dec 31, 2025 | Jun '25 Jun 30, 2025 | Jun '24 Jun 30, 2024 | Jun '23 Jun 30, 2023 | Jun '22 Jun 30, 2022 | Jun '21 Jun 30, 2021 | 2020 - 2016 |
| Revenue | 1.36 | 1.73 | 2.13 | 2.33 | 2.01 | 2.8 | Upgrade
|
| Revenue Growth (YoY) | -34.21% | -18.70% | -8.45% | 16.00% | -28.27% | 21.19% | Upgrade
|
| Cost of Revenue | 0.7 | 0.91 | 1.26 | 1.5 | 1.26 | 1.49 | Upgrade
|
| Gross Profit | 0.66 | 0.82 | 0.88 | 0.83 | 0.75 | 1.31 | Upgrade
|
| Selling, General & Admin | 1.84 | 1.95 | 2.16 | 2.66 | 4.16 | 3.95 | Upgrade
|
| Other Operating Expenses | 0.47 | 0.33 | 0.29 | 0.52 | 0.73 | 1.15 | Upgrade
|
| Operating Expenses | 2.32 | 2.28 | 2.45 | 3.18 | 4.89 | 5.1 | Upgrade
|
| Operating Income | -1.65 | -1.45 | -1.58 | -2.35 | -4.15 | -3.79 | Upgrade
|
| Interest Expense | - | -0 | -0 | - | -0.02 | -0.06 | Upgrade
|
| Interest & Investment Income | 0.02 | - | - | 0 | - | - | Upgrade
|
| Earnings From Equity Investments | - | - | - | -0.25 | -0.34 | -0.47 | Upgrade
|
| Other Non Operating Income (Expenses) | 0.01 | 0 | 0 | 0.07 | 0.27 | 0.37 | Upgrade
|
| EBT Excluding Unusual Items | -1.62 | -1.45 | -1.58 | -2.53 | -4.25 | -3.95 | Upgrade
|
| Gain (Loss) on Sale of Investments | - | - | 0.03 | 0.22 | - | - | Upgrade
|
| Gain (Loss) on Sale of Assets | - | - | -0 | 0.05 | -0.03 | -0 | Upgrade
|
| Asset Writedown | - | - | - | -0.09 | -0.84 | 0.33 | Upgrade
|
| Pretax Income | -1.62 | -1.45 | -1.55 | -2.35 | -5.12 | -3.63 | Upgrade
|
| Earnings From Continuing Operations | -1.62 | -1.45 | -1.55 | -2.35 | -5.12 | -3.63 | Upgrade
|
| Earnings From Discontinued Operations | 0 | -0.13 | -0.35 | -1.69 | -0.25 | - | Upgrade
|
| Net Income | -1.62 | -1.58 | -1.9 | -4.04 | -5.37 | -3.63 | Upgrade
|
| Net Income to Common | -1.62 | -1.58 | -1.9 | -4.04 | -5.37 | -3.63 | Upgrade
|
| Shares Outstanding (Basic) | 285 | 137 | 132 | 130 | 100 | 96 | Upgrade
|
| Shares Outstanding (Diluted) | 285 | 137 | 132 | 130 | 100 | 96 | Upgrade
|
| Shares Change (YoY) | -80.27% | 4.25% | 1.07% | 30.10% | 4.94% | 22.54% | Upgrade
|
| EPS (Basic) | -0.01 | -0.01 | -0.01 | -0.03 | -0.05 | -0.04 | Upgrade
|
| EPS (Diluted) | -0.01 | -0.01 | -0.01 | -0.03 | -0.05 | -0.04 | Upgrade
|
| Free Cash Flow | -1.54 | -1.62 | -1.11 | -1.65 | -3.8 | -2.51 | Upgrade
|
| Free Cash Flow Per Share | -0.01 | -0.01 | -0.01 | -0.01 | -0.04 | -0.03 | Upgrade
|
| Gross Margin | 48.77% | 47.50% | 41.10% | 35.52% | 37.09% | 46.80% | Upgrade
|
| Operating Margin | -121.44% | -83.82% | -73.91% | -100.84% | -206.53% | -135.36% | Upgrade
|
| Profit Margin | -119.12% | -91.08% | -89.09% | -173.51% | -267.37% | -129.62% | Upgrade
|
| Free Cash Flow Margin | -113.43% | -93.13% | -51.88% | -70.83% | -189.02% | -89.52% | Upgrade
|
| EBITDA | -1.65 | -1.45 | -1.57 | -2.16 | -3.89 | -3.56 | Upgrade
|
| EBITDA Margin | -121.41% | -83.81% | -73.77% | -92.51% | -193.77% | -126.94% | Upgrade
|
| D&A For EBITDA | 0 | 0 | 0 | 0.19 | 0.26 | 0.24 | Upgrade
|
| EBIT | -1.65 | -1.45 | -1.58 | -2.35 | -4.15 | -3.79 | Upgrade
|
| EBIT Margin | -121.44% | -83.82% | -73.91% | -100.84% | -206.53% | -135.36% | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.